O. Kozawa et al., EFFECTS OF GLUCOCORTICOID ON SIGNALING BY PROSTAGLANDIN-E(2) IN OSTEOBLAST-LIKE CELLS, Prostaglandins, leukotrienes and essential fatty acids, 49(5), 1993, pp. 867-872
It is well-known that osteoporosis is a common complication of patient
s with glucocorticoid excess. We previously reported that dexamethason
e inhibits Ca2+ influx induced by prostaglandin E2 (PGE2), a potent bo
ne resorbing agent, in osteoblast-like MC3T3-E1 cells (0. Kozawa, H. T
okuda, J. Kotoyori, A. Suzuki, Y. Ito and Y. Oiso, Prostagland Leuk Es
sent Fatty Acids, in press). In the present study, we examined the eff
ects of dexamethasone on cyclic adenosine monophosphate (cAMP) accumul
ation and phosphoinositide hydrolysis by PGE2 in MC3T3-E1 cells. The p
retreatment with dexamethasone significantly inhibited cAMP accumulati
on stimulated by PGE2 in a dose-dependent manner in the range between
10 pM and 1 nM in MC3T3-E1 cells. This effect of dexamethasone was dep
endent on the time of pretreatment up to 8h. Dexamethasone also inhibi
ted the cAMP accumulation induced by NaF, an activator of guanosine tr
iphosphate (GTP)-binding protein, or forskolin which directly activate
s adenylate cyclase. In contrast, dexamethasone had little effect on t
he formation of inositol phosphates stimulated by PGE2 in MC3T3-E1 cel
ls. These results strongly suggest that glucocorticoid modulates the s
ignal transduction by PGE2 in osteoblast-like cells and that it inhibi
ts PGE2-induced cAMP production without affecting PGE2-induced phospho
inositide hydrolysis.